ArticleClinical drug investigation2025

Super Responder Profile Under Bimekizumab Treatment in Moderate-to-Severe Psoriasis: A Short Term Real-Life Observation-IL PSO (Italian Landscape Psoriasis).

Maria Esposito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.